Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism

NCT03490513 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT03490513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03490513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism
Lead sponsor
Baylor College of Medicine
Phase
Phase 4
Overall status
Completed
Start date
April 15, 2018
Completion date
May 31, 2025
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, hypogonadotropic, obesity